Drug Discovery News
-
Korea's Dongsung Pharmaceuticals opens a new cancer research center in Seoul
Drug Discovery | News | 0 Comment | 14 Nov, 2017
In a bid to further strengthen its pipeline of cancer treatments, Korea’s Dongsung Pharmaceuticals has recently op...Read more
-
Helperby Therapeutics develops sustainable solution for antibiotic resistance
Drug Discovery | News | 0 Comment | 13 Nov, 2017
UK based pharma company, Helperby Therapeutics has developed Antibiotic Resistance Breakers (ARBs) as a solution to the ...Read more
-
Amgen And Novartis announce expanded collaboration with Banner Alzheimer's Institute
Drug Discovery | News | 0 Comment | 03 Nov, 2017
Singapore – Amgen and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to ...Read more
-
Boehringer Ingelheim and Dicerna collaborate to develop treatments for chronic liver diseases
Drug Discovery | News | 0 Comment | 02 Nov, 2017
Pharma company Boehringer Ingelheim and leading developer of RNAi therapeutics Dicerna Pharmaceuticals has announced a r...Read more
-
Evolution of drug delivery system for better patient safety
Drug Discovery | News | 0 Comment | 01 Nov, 2017
Chronic conditions such as diabetes, multiple sclerosis and rheumatoid arthritis are on the rise and often require daily...Read more
-
CFDA accepts Eisai's NDA for cancer drug
Drug Discovery | News | 0 Comment | 31 Oct, 2017
Eisai Co., Ltd. announced that the China Food and Drug Administration (CFDA) has accepted for review a New Drug Ap...Read more
-
New 'Double Decker' Antibody Technology Fights Cancer
Drug Discovery | News | 0 Comment | 26 Oct, 2017
Singapore - Scientists from the Florida campus of The Scripps Research Institute (TSRI) have created...Read more
-
Alopexx completes first-in-man trial of its novel, broad-spectrum anti-microbial vaccine
Drug Discovery | News | 0 Comment | 26 Oct, 2017
Singapore - Alopexx Vaccine LLC (a US- based science driven investment company) announced that it has completed a Phase ...Read more
-
Incyte and MacroGenics collaborates for anti-PD-1 monoclonal antibody
Drug Discovery | News | 0 Comment | 26 Oct, 2017
Biopharma company, Incyte Corporation and MacroGenics has announced that the companies have entered into an exclusi...Read more
-
AbbVie plows $205M upfront Into Alector's Alzheimer's Program
Drug Discovery | News | 0 Comment | 25 Oct, 2017
AbbVie announced a strategic collaboration with South San Francisco-based Alector to develop and commercialize drugs for...Read more
-
Eisai, Biogen expand their agreement to codevelop and commercialize AD drug
Drug Discovery | News | 0 Comment | 24 Oct, 2017
Japan’s Eisai and US based Biogen announced the expansion of their existing collaboration agreement ...Read more
-
Drug Discovery | Opinion | 2 Comment | 13 Oct, 2017
Q. Can you briefly explain this new blood testing technology and how is it different from the more conventional tests th...Read more
-
Novel bi-specific antibody shows strong therapeutic potential to treat Zika virus infection
Drug Discovery | News | 0 Comment | 12 Oct, 2017
Singapore - The Journal Cell published data with a bi-specific antibody against Zika virus infection. The article is ent...Read more
-
Drug Discovery | News | 0 Comment | 10 Oct, 2017
Singapore – Johnson & Johnson (J&J) announced the launch of its three-monthly long-acting treatment for sc...Read more
-
Chiome Bioscience selects ProBioGen for GlymaxX antibody manufacturing program
Drug Discovery | News | 0 Comment | 05 Oct, 2017
ProBioGen AG, a premier service & technology provider for complex therapeutic glycoproteins and Chiome Bioscience In...Read more
-
Regulatory approval in Europe granted for Synthon's Glatiramer Acetate
Drug Discovery | News | 0 Comment | 05 Oct, 2017
Synthon announced that it has successfully concluded the decentralized procedures for glatiramer acetate 40 mg/ml pre-fi...Read more
-
Sato And Eisai Pharma co-promote antifungal agent in Japan
Drug Discovery | News | 0 Comment | 03 Oct, 2017
Sato Pharmaceutical Co. Ltd., Eisai Co. Ltd., and Seren Pharmaceuticals Inc. announced that Sato Pharma and Eisai will c...Read more
-
Korea to inject 500 billion won into pharma sector; aims to launch 100 new drugs by 2026
Drug Discovery | News | 0 Comment | 30 Sep, 2017
In a bid to place Korea on the biotech global map, the Korean government announced plans to will inject 500 ...Read more
